Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy

por Forget, Marie-Andrée, Malu, Shruti, Liu, Hiu, Toth, Christopher, Maiti, Sourindra, Kale, Charuta, Bernatchez, Chantale, Huls, Helen, Wang, Ena, Hwu, Patrick, Cooper, Laurence J, Radvanyi, Laszlo G
Publicado 2013

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy

por Chen, Jieqing, Creasy, Caitlin, Torres-Cabala, Carlos Antonio, Ekmekcioglu, Suhendan, Maiti, Sourindra N, Kale, Charuta, Haymaker, Cara, Roszik, Jason, Bassett, Roland L, Hu, Jianhua, Wang, Zhiqiang, Ma, Wencai, Davis, R Eric, Bernatchez, Chantale, Hwu, Patrick, Radvanyi, Laszlo
Publicado 2014